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Abstract: A subset of proteins containing NlpC/P60 domains are bacterial peptidoglycan hydrolases that cleave noncanonical peptide linkages and contribute to cell wall remodeling as well as
cell separation during late stages of division. Some of these proteins have been shown to cleave
peptidoglycan in Mycobacterium tuberculosis and play a role in Mycobacterium marinum virulence
of zebra fish; however, there are still significant knowledge gaps concerning the molecular function
of these proteins in Mycobacterium avium subspecies paratuberculosis (MAP). The MAP genome
sequence encodes five NlpC/P60 domain-containing proteins. We describe atomic resolution crystal structures of two such MAP proteins, MAP_1272c and MAP_1204. These crystal structures,
combined with functional assays to measure peptidoglycan cleavage activity, led to the observation that MAP_1272c does not have a functional catalytic core for peptidoglycan hydrolysis. Furthermore, the structure and sequence of MAP_1272c demonstrate that the catalytic residues
normally required for hydrolysis are absent, and the protein does not bind peptidoglycan as efficiently as MAP_1204. While the NlpC/P60 catalytic triad is present in MAP_1204, changing the catalytic cysteine-155 residue to a serine significantly diminished catalytic activity, but did not affect
binding to peptidoglycan. Collectively, these findings suggest a broader functional repertoire for
NlpC/P60 domain-containing proteins than simply hydrolases.
Keywords: Mycobacterium; Johne’s disease; crystal structure; peptidoglycan; proteins; antigens;
paratuberculosis
Additional Supporting Information may be found in the online version of this article.
Importance: Johne’s disease in ruminant livestock is caused by the bacterium Mycobacterium avium subspecies paratuberculosis. This
research describes the functional aspects of two proteins that show promise in a subunit vaccine for Johne’s disease. Through crystal
structure determination and amino acid modification, we demonstrate that although both proteins have a similar structure, one of them
lacked hydrolytic activity on peptidoglycan. We show that a specific amino acid is likely responsible for this lack of hydrolytic activity.
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Introduction
Mycobacterium avium subspecies paratuberculosis
(MAP) causes a chronic intestinal disease of ruminants including cattle, sheep, and goats. This disease,
termed Johne’s disease, has a worldwide distribution
and >90% prevalence in U.S. dairy cattle herds,1
which results in an economic toll of more than 200
million dollars annually.2 The bacterium is transmitted from cow-to-calf via the fecal–oral route and
through contaminated milk. Thus, a multipronged
research approach that encompasses epidemiology,
pathogenesis, diagnostics, vaccine development, and
ideal herd management strategies is warranted to
reduce the impact of Johne’s disease on farms.3–5
This economically significant veterinary pathogen is among the Mycobacteria which all contain a
unique cell wall structure that includes mycolic acids
covering the lipoarabinogalactan layer with a foundational lattice of muropeptide cross-linked peptidoglycan.6 Implicit with this sturdy cell wall are hydrolytic
mechanisms required for cell division, peptidoglycan
remodeling, nutrient uptake, as well as other biological processes. Thus the peptidoglycan layer in particular must be constantly modified during growth and
at least partially disassembled to separate daughter
cells during the final stages of cell division. This is
accomplished by three classes of enzymes: glycosidases, which cleave bonds between the repeating
disaccharides; amidases, which hydrolyze the bond
between the peptide moiety and the N-acetylmuramic
acid; and finally, the NlpC/P60 endopeptidases, which
cleave the interchain bonds of the muropeptide. The
high lipid content and heavy cross-linking of these
layers in the cell wall is thought to enable mycobacteria to resist antibiotics, UV exposure, heat treatment,
and other environmental insults.7–10
Proteins containing the NlpC/P60 superfamily
domain (pfam00877) are important in bacterial
physiology11 and virulence.12,13 A Mycobacterium
tuberculosis gene, Rv2190c, encodes an NlpC/P60
protein that is required for virulence in the mouse
model of TB and was shown to be immunogenic in
the context of infection.12 The NlpC/P60 domain typically has hydrolytic activity and enzymes containing this domain include acyltransferases, amidases,
and endopeptidases.11 NlpC/P60 proteins have also
been localized at the septa of dividing bacteria and
mutations are phenotypically manifested by septation defects,14,15 suggesting a role in separation of
daughter cells during cell division or general maintenance of the cell wall.16 Two genes in Mycobacterium marinum, a fish pathogen, which encode NlpC/
P60 domain-containing proteins are required for
infection in zebra fish and cord formation seen in
virulent mycobacteria,13 thus adding to the diverse
functions associated with proteins containing this
domain.
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The MAP genome sequence encodes a total of
five NlpC/P60 domain-containing proteins, which
have been designated MAP_0036, MAP_1203 (ortholog of RipA in M. tuberculosis), MAP_1204 (RipB in
M. tuberculosis), MAP_1272c (RipD in M. tuberculosis), and MAP_1928c (Rv2190c in M. tuberculosis) in
the bovine strain K-10.17 This is the same number of
NlpC/P60 proteins annotated in M. tuberculosis12
and Corynebacterium glutamicum genomes.15
MAP_1203 shows increased expression, nearly 25fold, when MAP is exposed to milk,18 a hyperosmolar environment that triggers a more invasive form
of the bacterium. Although both MAP_1204 and
MAP_1272c proteins are immunogenic, MAP_1272c
in particular has been observed as a strong antigen
in multiple studies.19–21 Our group has also evaluated MAP_1204 and MAP_1272c as part of a subunit vaccine cocktail against Johne’s disease in
mice.21 Those results showed a significant decrease
in MAP colonization of the vaccinated mouse intestine. Two monoclonal antibodies were also developed
against MAP_1272c and their binding sites and biochemical properties have been determined.19 We
have now extended those studies by examining the
structure and catalytic properties of these proteins
in MAP. Here we demonstrate that while both proteins display a conserved substrate-binding groove,
one NlpC/P60 domain-containing protein hydrolyzes
peptidoglycan while a second one is nonhydrolytic.

Results
Characteristics of MAP_1204 and MAP_1272c
Based on BLAST analysis of the NCBI sequence
database combined with experimental data,19 we
suggest that the MAP_1272c protein is 279 amino
acids in length (29.2 kDa) and not 316 as annotated
in the K-10 genome sequence.17 MAP_1204 encodes
a 244 amino acid protein with a calculated molecular
weight of 25.4 kDa. Both proteins contain an Nterminal signal sequence predicted by the SignalP
4.1 server.22 MAP_1204 cleavage is predicted
between Ala-33 and Asp-34, whereas MAP_1272c
cleavage is predicted between Ala-29 and Asp-30 of
the revised annotation. While MAP_1204 contains a
canonical NlpC/P60 domain near its C-terminal end
(amino acids 128–243) similar to most mycobacterial
NlpC/P60 proteins, the domain is more centrally
located in MAP_1272c (Fig. 1). Specifically, it is
present at 52–166 amino acids in MAP_1272c, followed by a glutamine-rich region (169–273) containing the repeat sequence (QQAPLQ)6 .

NlpC/P60 domain structures in MAP_1272c and
MAP_1204
A truncated form of MAP_1272c, consisting of residues 27–168, was overexpressed, purified, and
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Figure 1. Schematic of the five NlpC/P60 domain-containing
proteins present in the MAP genome. Locations of the NlpC/
P60 domain within each protein are shown drawn to scale
based upon their preproteins; enzymatically active domains
are colored grey while inactive domains are white. The locations of signal peptide regions are designated with a striped
box. The dotted region at the C-terminus of MAP_1272c represents a polyglutamine repeat of unknown structure and
function.

crystallized. These crystals belong to the primitive
monoclinic space group P21 and diffracted X-rays to
1.75 Å Bragg-limiting resolution. The truncated
MAP_1272c structure (Protein Data Bank entry
3GT2) was determined ab initio by singlewavelength anomalous dispersion (SAD) phasing
using diffraction data collected from crystals of protein labeled in vivo with selenium-substituted methionine. This structure was refined to R/Rfree values of
18.3 and 20.1%, respectively (Table I). Similarly, a
truncated form of MAP_1204, consisting of residues
109–244, was overexpressed, purified, and crystallized. These crystals belong to the primitive cubic
space group P213 and diffracted X-rays to 2.4 Å
Bragg-limiting resolution. The truncated MAP_1204
structure (Protein Data bank Entry 3I86) was determined by molecular replacement using the refined
truncated MAP_1272c structure as a search model.
This structure was subsequently refined to R/Rfree
values of 22.0 and 28.0%, respectively (Table II).
The structures of the two NlpC/P60 domains are
characterized by a helix–loop–helix in their Nterminal regions, while their C-terminal regions contain a b hairpin motif consisting of six antiparallel
strands [Fig. 2(A)]. As might be expected for two
proteins that share 52% sequence identity with one
another, the structures of MAP_1204 and
MAP_1272c share a high level of structural homology when superimposed (Supporting Information,
Fig. S1); 135 of 136 residues align within 5.0 Å distance with a root-mean-square deviation (RMSD) of
0.69 Å. Consistent with these minor differences in
tertiary structure, both MAP_1272c and MAP_1204
share a striking feature when viewed as molecular
surfaces. Specifically, an elongated groove is formed
at the interface between the helix–loop–helix and b
hairpin regions [Fig. 2(B)]. This grove very likely
represents a substrate access channel since residues
that comprise the canonical catalytic triad of NlpC/
P60 domains lie at the center of the groove (as is
discussed below). Nevertheless, comparison of the
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electrostatic surface potentials within this groove
shows notable differences between MAP_1272c and
MAP_1204 [Fig. 2(C)]. Whereas the MAP_1204
channel is largely uncharged, the corresponding surface from MAP_1272c appears highly acidic. Given
the proximity of this groove to the NlpC/P60 active
site, these electrostatic differences may reflect both
the substrate/ligand preferences and distinct physiological roles of MAP_1204 and MAP_1272c, though
the specific function of MAP_1272c remains unclear.
Considering NlpC/P60 domains more broadly,
extensive homology between MAP_1272c and
MAP_1204 is also found in M. tuberculosis RipD
(Rv1566c), which is the most closely related structure
in the PDB (4JXB; 87% identity to MAP_1272c).23
However, when the MAP structures are superimposed
onto other more distantly related NlpC/P60 domains,
such as those found in Bacillus cereus BCE_2878
(3H41; 36% identity)24 and Desulfovibrio vulgaris
DVU_0896 (3M1U; 20% identity; unpublished), more
structural diversity becomes evident (Fig. 3). While
this diversity expectedly becomes more significant as
Table I. Data Collection Statistics, Determination, and
Refinement for MAP_1272c
Data collection and
structure solution

Parameters
Beamline
Wavelength (Å)
Space group
Unit cell dimensions (Å; 8)
Molecule/ASU
Resolution limits (Å)
Completeness (%)
Total reflections
Unique reflections
Rmerge (%)b
I>/<r
Redundancy
Heavy atom sites (Se)
Figure of Merit <m>
Refinement statistics
Rcryst/Rfree (%)c
RMS deviations from ideality
Bond length (Å)
Bond angle (8)
Dihedral angle (8)
Ramachandran core (disallowed) (%)
Average B factor (Å2)
RMSD of B factor (Å2)
Proteins atoms modeled
Ordered solvent molecules

APS 22-ID
0.97242
P21
a 5 34.72, b 5 53.21,
c 5 38.33; b 5 102.95
1
22.68–1.75
(1.81–1.75)a
96.1 (78.1)
47,147
13,278
7.2 (21.6)
9.45 (3.31)
3.6
7
0.64
18.3/20.1
0.006
0.971
15.002
93.3 (1.9)
23.63
6.37
993
100

a
Numbers in parentheses correspond to the highest resolution shell.
b
Rmerge 5 RhRi|Ii(h) 2 <I(h)>|/RhRiIi(h), where Ii(h) is the
ith measurement of reflection h and <I(h)> is the weighted
mean of all measurements of h.
c
R 5 Rh|Fobs(h) 2 Fcalc(h)|/RhjFobs|. Rcryst and Rfree were
calculated from the working and test reflection sets, respectively. The test set constituted 10% of the total reflections
not used in refinement.
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Table II. Data Collection Statistics, Determination,
and Refinement for MAP_1204
Parameters
Beamline
Wavelength (Å)
Space group
Unit cell dimensions (Å)
Resolution limits (Å)
Completeness (%)
Total reflections
Unique reflections
Rmerge (%)b
I>/<r
Redundancy
Refinement statistics
Rcryst/Rfree (%)c
RMS deviations from ideality
Bond length (Å)
Bond angle (8)
Dihedral angle (8)
Ramachandran core (disallowed) (%)
Average B factor (Å2)
RMSD of B factor (Å2)
Proteins atoms modeled
Ordered solvent molecules

Data collection and
structure solution
APS 22-BM
1.000
P21 3
a 5 97.11
43.43–2.40
(2.64–2.40)a
99.6 (100)
12,254
1,213
16.9 (85.6)
14.1 (2.2)
13.0
22.0/28.0
0.008
1.21
16.995
91.1 (1.9)
30.21
7.72
2042
45

a
Numbers in parentheses correspond to the highest resolution shell.
b
Rmerge 5 Rh Ri|Ii(h) 2 <I(h)>|/Rh RiIi(h), where Ii(h) is
the ith measurement of reflection h and <I(h)> is the
weighted mean of all measurements of h.
c
R 5 Rh|Fobs(h) 2 Fcalc(h)|/Rh RFobs|. Rcryst and Rfree were
calculated from the working and test reflection sets, respectively. The test set constituted 5% of the total reflections
not used in refinement.

identity decreases, it is important to note that most of
the divergence is seen in regions removed from the
NlpC/P60 catalytic core. Much similar to the changes
in electrostatic potential mentioned above, these
structural differences at the active site periphery
have probably accompanied alterations in substrate/
ligand specificity and function during the evolution of
NlpC/P60 domain-containing proteins.

Divergent catalytic triads in MAP_1204 and
MAP_1272c
A catalytic triad that consists of a cysteine, histidine, and a polar residue enables the hydrolytic
activity that is conserved within the NlpC/P60
superfamily.11 In this regard, all but one of the MAP
NlpC/P60 proteins contain the signature motif
“FDCSGL,” where the cysteine residue is part of the
catalytic triad. The lone exception to this is
MAP_1272c, where the Cys residue at position 82 is
replaced by Ala [Fig. 4(A)]. Amino acid sequence
alignment of other mycobacterial homologs of
MAP_1272c shows the same alanine residue is conserved (Supporting Information, Fig. S2). However,
alignment with all MAP NlpC/P60 proteins, except
MAP_1272c, to corresponding mycobacterial homo-
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logs shows the cysteine residue is preserved (Supporting Information, Figs. S3–S6).
Similar to MAP_1272c and MAP_1204, the putative cell wall anchored hydrolase, Spr, from Escherichia coli also belongs to the NlpC/P60
superfamily.25 The catalytic triad for Spr includes
Cys-68, His-119, and His-131.25 Superimposition of
the Spr and MAP_1272c structures reveals that the
amino acid side chains in the corresponding locations of MAP_1272c are Ala-82, Ser-131, and Glu143 [Fig. 4(B)]. Although it is interesting to note
that these three side chains do not adopt the same
relative orientations in MAP_1272c as is found in
Spr, the lack of a substrate or substrate analog in
either crystal precludes a more thorough consideration of the functional consequences of such differences. Nevertheless, there is no proton in the alanine
side chain that is sufficiently acidic as to be capable
of generating a nucleophile that facilitates substrate
hydrolysis. Intriguingly, this limitation is not seen
for MAP_1204, where side chain orientations of catalytic triad residues Cys-155, His-204, and Glu-216
are congruent with one another [Fig. 4(C)].

MAP_1272c, but not MAP_1204, lacks hydrolytic
activity against Bacillus subtilis peptidoglycan
Given the apparent absence of a catalytic site in
MAP_1272c, we hypothesized that this mycobacterial NlpC/P60 protein may not have hydrolytic activity akin to that predicted for the E. coli Spr
protein.25 To test this hypothesis, a suitable assay
was designed to assess bacterial survival in the
presence of exogenous quantities of peptidoglycan
remodeling enzymes. The concept of this assay is
straightforward in that the integrity of the bacterial
cell should be compromised in the presence of NlpC/
P60 hydrolase activity, and that cell wall integrity is
essential for cell viability. Because the long generation time of MAP makes its use impractical for survival assays, we used Bacillus subtilis as a model
Gram-positive system for the studies presented here.
The B. subtilis peptidoglycan substrate was also chosen since its muropeptide sequence (L-Ala, D-Glu,
meso-diaminopimelic acid, D-Ala) is identical with
that present in mycobacterial peptidoglycan.26
To establish whether MAP proteins were capable of acting upon B. subtilis peptidoglycan layers,
we first assessed B. subtilis survival in the presence
of MAP_0318. MAP_0318 is 85% identical to M.
tuberculosis Rv3717, which is an N-acetylmuramylL-alanine amidase known to play a role in cell wall
formation and remodeling.27 Indeed, incubation with
exogenously added MAP_0318 significantly diminished B. subtilis survival compared to the irrelevant
control protein, IpaD, from Shigella flexneri [Fig.
5(A)]. A significant decrease in B. subtilis viability
was also observed in the presence of MAP_1204 [Fig.
5(A)], suggesting that this NlpC/P60 protein is
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Figure 2. Three-dimensional structures of NlpC/P60 domains from MAP_1272c and MAP_1204. (A) Refined 1.75 Å resolution
structure of MAP_1272c and 2.4 Å resolution structure of MAP_1204. The proteins are rendered as cartoons with the Nterminus in red and the C-terminus in blue. (B) Molecular surface of MAP_1272c and MAP_1204, where residues of the catalytic
triad are colored light orange. Note that the dashed white lines represent the boundaries of putative substrate/ligand-binding
channels in each protein. (C) Distribution of electrostatic potential at the surface of each protein contoured at 65e/kT. The orientation of all structures has been kept constant in each panel for clarity.

capable of hydrolyzing substrates found in B. subtilis
peptidoglycan. To test whether this activity required
an intact catalytic triad, we overexpressed and puri-

fied a mutant form of MAP_1204 where the active
site Cys-155 was replaced with serine (MAP_1204C155S). As expected, B. subtilis cells exposed to this

Figure 3. Superposition of NlpC/P60 domains from MAP_1272c with non-mycobacterial NlpC/P60 domain-containing proteins.
(A) Shown is superposition of MAP_1272c (blue) and B. cereus BCE_2878 (magenta) and (B) superposition of NlpC/P60
domains from MAP_1272c (blue) and D. vulgaris DVU_0896 (rust). Note that residues of the MAP_1272c catalytic triad are colored light orange for the purposes of orientation. The orientation of all structures is identical to that shown in Figure 2.

844

PROTEINSCIENCE.ORG

Mycobacterium paratuberculosis NlpC/P60 Proteins

Figure 4. Comparison of the catalytic triads of MAP NlpC/P60 proteins, and E. coli Spr. (A) Shown is a partial alignment of the
five MAP proteins surrounding the cysteine catalytic residue. Conserved amino acids among all 5 proteins are highlighted and
the catalytic residue is shown in red. (B) Three-dimensional overlay of MAP_1272c (blue) with E. coli Spr (grey). Residues comprising the catalytic triads have been rendered as ball-and-stick and colored distinctly for MAP_1272c (orange) and Spr (cyan).
(C) Overlay of MAP_1204 (blue) with E. coli Spr (grey). Residues comprising the catalytic triads have been rendered as balland-stick and colored distinctly for MAP_1204 (orange) and Spr (cyan). The identity and position of each residue of interest is
inset.

mutant did not display a significant decrease in cell
viability [Fig. 5(A)], even though this site-directed
mutation exhibited nearly identical structural features to its wild-type counterpart as judged by circular
dichroism
spectropolarimetry
(Supporting
Information, Fig. S7). Similarly, B. subtilis exposed to
exogenously added MAP_1272c showed little or no
decrease in viability [Fig. 5(A)]; in fact, this result
was largely indistinguishable from that obtained for
the MAP_1204 active site mutant.
This study was expanded using B. subtilis peptidoglycan fragments obtained commercially to rule
out any potential nonspecific effects on B. subtilis
viability. This purified peptidoglycan was incubated
with each protein and degradation was measured for
optical clearance at 540 nm over time. Both the nontagged and MBP-tagged MAP_1204 proteins hydrolyzed peptidoglycan as did MAP_0318 [Fig. 5(B)].
Conversely, MAP_1272c and MAP_1204 C155S did
not degrade peptidoglycan.
Collectively, these data demonstrate that
MAP_1204 is an active peptidoglycan hydrolase and
indicate that mutation of the proposed catalytic Cys155 residue greatly diminishes the enzyme’s activity.
Furthermore, the functional differences in the
MAP_1204 and MAP_1204 C155S proteins are likely
due to loss of specific side chains rather than altered
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protein structure (Supporting Information, Fig. S7).
These results are also consistent with the notion that
MAP_1272c lacks the hydrolytic activity characteristic of most other members of the NlpC/P60 family.
Similarity searches suggest that this catalytic cysteine is missing only in mycobacteria. Thus, we propose
that MAP_1272c is a noncatalytic member of the
NlpC/p60 family found only in Mycobacterium spp.

MAP_1272c does not bind peptidoglycan as
efficiently as MAP_1204
Both MAP_1272c and MAP_1204 have what appears
to be a substrate-binding groove on their surface.
However, since MAP_1204 hydrolyzes peptidoglycan
while MAP_1272c does not, we investigated whether
both of these proteins might bind peptidoglycan
[Fig. 2(B)]. Purified recombinant proteins were
tested for their ability to bind insoluble peptidoglycan fragments from B. subtilis. Consistent with the
functional assays in Figure 5, MAP_1204 was able
to bind peptidoglycan since this protein accumulated
in the pellet with the peptidoglycan [Fig. 6(A)]. Conversely, MAP_1272c was observed primarily in the
supernatant suggesting that MAP_1272c has only
weak affinity for peptidoglycan. The positive control,
lysozyme, did bind peptidoglycan, whereas the negative control, BSA, did not [Fig. 6(A,B)]. The MBP
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growth of bacteria.13 As a consequence, members of
this family of enzymes are considered attractive
targets for next-generation antibiotic development.
A notable validation of NlpC/P60 proteins as antibiotic targets has been done for M. marinum IipA
(homolog of MAP_1203), where the gene knockout
was constructed and complemented to show a lack
of growth and infectivity in macrophages.13 Since
MAP is resistant to many antibiotics,28,29 novel
approaches must be explored in treating infections
by this organism. Furthermore, since NlpC/P60
proteins are found in all Eubacteria, any compounds that are capable of inhibiting these
enzymes have the potential to be developed into

Figure 5. Measurement of hydrolytic activity using B. subtilis
and peptidoglycan substrates. (A) Effect of MAP NlpC/P60
domains on viability of B. subtilis. Actively growing B. subtilis
cells were incubated with 32 lM of each NlpC/P60 domain
protein, known peptidoglycan modifying enzymes (e.g., hen
egg white lysozyme (HEWL, 4 lM), or a negative control protein (i.e., S. flexneri IpaD) and plated to assess bacterial viability as described in materials and methods. Total colony
forming units were counted, and the results were compared
to a mock treatment (culture medium alone) to assess the
percent loss of viability. The mean values of each treatment
(6SD) were calculated and compared to that of the negative
control (IpaD) by an unpaired t-test to assess statistical significance. ****p  0.0001; ns, not significant. (B) Hydrolytic
activity of MAP_1204 and MAP_1272c on B. subtilis peptidoglycan measured at 540 nm over time. BSA and HEWL are
positive and negative controls, respectively.

fusions of MAP_1204 and MAP_1272c showed the
same peptidoglycan binding characteristics as their
untagged counterparts, yet the size of the MBP
fusion proteins eliminated comigration with the peptidoglycan fragments [Fig. 6(B)]. Both the wild-type
and C155S mutant of MAP_1204 bound peptidoglycan in a similar manner [Fig. 6(C)], suggesting that
a mutation in the catalytic site did not significantly
affect binding, only hydrolysis. Thus, it remains
unknown as to what substrate is recognized by the
binding groove on the surface of MAP_1272c.

Discussion
Both serendipitous and engineered deletions of
NlpC/P60 protein-encoding genes have been shown
by others to reduce pathogenicity and vegetative
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Figure 6. SDS-PAGE analysis of fractions from the peptidoglycan binding assay. MAP proteins without terminal tags are
shown (A) along with positive (HEWL) and negative (BSA)
controls. I 5 input protein, F 5 free/unbound protein from the
supernatant, and B 5 bound protein from the pellet fraction.
(B) MBP–MAP fusion proteins are shown along with positive
(HEWL) and negative (BSA) controls. (C) The wild type and
mutant (C155S) forms of MAP_1204 bound peptidoglycan in
a similar manner. Protein size standards (in kDa) are at the
left of each image.

Mycobacterium paratuberculosis NlpC/P60 Proteins

new, broad-spectrum antibiotics. In this regard,
the structural information presented here, combined with mutagenesis data consistent with identification of an active site and a slight, but
functionally significant variation therein may
prove useful in future screening for such inhibitory
compounds.
Substitution of the catalytic cysteine of Rv1477
(MAP_1203 homolog) to an alanine demonstrated
that Cys383 is an essential catalytic amino acid for
peptidoglycan hydrolysis.30 Likewise, a separate
study showed that mutation of glutamic acid to alanine in Rv1477 inactivates catalysis by changing the
spatial configuration of Cys383.31 However, no one
has examined Rv1478 or its counterpart, MAP_1204,
using mutational substitutions. Thus, our work
extends these findings by demonstrating that the
Cys-to-Ser substitution in MAP_1204 also renders
the NlpC/P60 domain enzymatically inactive but
does not affect binding to peptidoglycan.
During the course of preparing this manuscript,
it was reported that another mycobacterial protein,
RipD/Rv1566c from M. tuberculosis, also displayed a
conspicuous lack of hydrolase activity that we
observed for MAP_1272c.23 In fact, owing to the
high levels of identity between the RipD and
MAP_1272c NlpC/P60 domains mentioned above,
Both et al.23 used our refined model of MAP_1272c
to determine the structure of the RipD core domain.
RipD was shown to lack a catalytic cysteine, and the
same substitution of a cysteine for alanine within
the active site was reported for RipD as for
MAP_1272c. Furthermore, RipD contains 8 repeats
of QAPVQ at its C-termini, which is similar to the
six QQAPLQ repeats in MAP_1272c. Thus, it
appears that RipD is the M. tuberculosis ortholog of
MAP_1272c. However, given the implicit biochemical
restrictions to forming the NlpC/P60 catalytic triad,
and relative permissibility of the third position,
which requires only a polar residue,11 it seems likely
that noncatalytic NlpC/P60-containing proteins exist
in other bacteria and have yet to be discovered.
Both et al.23 have shown that noncatalytic forms
of NlpC/P60 domains have diversified to include peptidoglycan binding in addition to hydrolytic activities. The NlpC/P60 domain of RipD did bind
peptidoglycan fragments, but full-length RipD did
not. In our study, neither the full length nor the
Nlpc/P60 region of MAP_1272c was able to bind peptidoglycan. Importantly, our crystal structure of
MAP_1272c reveals a prominent, negatively charged
substrate/ligand-binding groove on the surface of
MAP_1272c. This observation further supports a
role for MAP_1272c as a ligand binding protein for a
substrate other than peptidoglycan, which tentatively broadens the role of NlpC/P60 domain containing proteins.
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Considerations of NlpC/P60 domains aside, both
catalytic and noncatalytic members of a protein family have been observed previously. One such example
is members of the NTF2-like protein superfamily.32
Here the catalytic forms include enzymes that function intracellularly in polyketide and natural product
biosynthesis,
while
the
extracellular,
noncatalytic proteins in this group possess small
molecule binding activity.32 Another example can be
derived from the chymotrypsin-like serine proteases
found in neutrophils. In this case, neutrophil azurophilic granules contain four enzymatically active serine proteases which include neutrophil elastase,
cathepsin G, proteinase-3, and neutrophil serine
protease-4 along with a single nonactive member,
named azurocidin.33–35 Interestingly, while azurocidin also contains point mutations that render its catalytic triad inactive,36 a body of literature has also
reported chemotactic and immunoregulatory activity
associated with release of azurocidin during inflammatory events (reviewed in Ref. 35). Thus, noncatalytic members of diverse protein families are not
simply restricted to ligand binding roles, but can
serve as signaling mediators as well.
When compared to other bacterial pathogens, a
lingering issue that confounds many of the overriding scientific advancements in MAP biology and
Johne’s disease is that there are comparatively few
reagent systems available. An extensive recombinant protein repository for MAP provides a vital and
powerful tool for proteome- and genome-scale
research of this organism.37 Such a resource makes
it possible to analyze the activities of proteins in cell
growth, maintenance, regulation, survival, and
pathogenesis. Additionally, this resource can provide
reagents for diagnostics38,39 and functional proteomic experiments, including both the structural studies described herein as well as defining protein–
protein interactions. Finally, tools such as this repository build on genomic information by aiding in the
functional annotation of the hundreds of hypothetical proteins. Therefore, this work continues to build
on important advances in understanding MAP biology for future countermeasures against Johne’s
disease.

Materials and Methods
Protein production and purification
Full-length
expression
and
purification
of
MAP_1203, MAP_1204, and MAP_1272c has been
described elsewhere using the maltose binding protein (MBP) expression system.19,37 In addition to
those MBP fusion proteins, truncated versions of
these genes were fused to a polyhistidine tag and
Tobacco Etch Virus (TEV) recognition site and subcloned into the E. coli expression vector pT7HMT
using methods previously described.40 A series of
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His-tagged MAP_1272c truncations have been
described in detail elsewhere19; however, this article
made extensive use of only a form of MAP_1272c
consisting of residues Ala27 to Thr168. Similarly,
MAP_1204 was truncated such that only the 136
residues from Val109 to Tyr244 were expressed. The
sequence-confirmed plasmids were transformed into
E. coli strain BL21(DE3) for overexpression and
purification, which were carried out according to the
general protocols outlined previously.40 Upon completing the initial affinity purification, the polyhistidine fusion tag was proteolytically removed by
adding recombinant TEV protease as described previously.40 The epitope tag, protease and most contaminating species were removed by IMAC
chromatography and the flow through was buffer
exchanged into 20 mM sodium formate buffer (pH
3.5). Final purification was achieved with Resource
S cation exchange chromatography using a GE Lifesciences Akta fast protein liquid chromatography
(FPLC) system using a linear gradient of 0–1M
NaCl in 20mM sodium formate pH 3.5.
MAP_1272c from the strain K-10 genome may
have been incorrectly annotated. Its 316 annotated
residues start with the sequence VRSQ; however, comparison with other annotations of M. avium complex
strains has suggested that this protein is likely only
279 residues long with translation beginning at the
Met38 of the annotated K-10 sequence. Therefore, we
adopted the convention used in our previous study
that set Met38 as Met1, making the full-length
MAP_1272c protein from 1 to 279 amino acids and the
first 25 amino acids comprising the signal sequence.19

Preparation of selenomethionine proteins
Escherichia coli methionine auxotroph strain
B834(DE3) was transformed with a plasmid encoding MAP_1272c residues Ala27–Thr168) and then
grown in 100 mL Luria Broth (LB) at 378C to an
OD600nm of 0.7. Cells were harvested by centrifugation and washed once with minimal media before
inoculation into 1 L of M9 minimal salts media supplemented with 5 mg L-(1)-selenomethione (SeMet).
Cells were grown at 378C to OD600nm of 0.75 and
then cooled to 188C. IPTG was added to 1 mM along
with an additional 5 mg SeMet. After overnight
induction at 188C, the protein was purified identically to the native sample.

Protein crystallization
The truncated MAP_1272c protein was dialyzed
extensively against ddH2O and concentrated by centrifugal ultrafiltration to 10 mg/mL as judged by UV
absorption spectrophotometry. Initial crystallization
screening was carried out by vapor diffusion of hanging drops using commercially available sparse-matrix
kits (Hampton Research, Aliso Viejo, CA). Optimized
crystals were produced by the hanging drop vapor
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diffusion technique. Rod-shaped crystals grew in
drops composed of 1 lL protein and 1 lL of well
buffer (0.1M BisTris–HCl, 1.6M ammonium sulfate,
4% (v/v) polyethylene glycol 400), and equilibrated
over 500 lL of the same buffer. Crystallization of the
selenomethionine-substituted protein was carried out
using an identical protocol. Crystals of the truncated
MAP_1204 protein were grown by hanging drop
vapor diffusion by mixing 1 lL protein at 10 mg/mL
in ddH2O with 1 lL of 1:1 diluted precipitant solution
containing 22% (w/v) polyethylene glycol 3,350, 10%
(v/v) 2-propanol, and 0.1M sodium HEPES, pH 7.5.
We also obtained crystals of a third NlpC/P60 protein,
MAP_1203, but these crystals did not diffract X-rays
in an interpretable manner.

Diffraction data collection, structure solution,
and refinement
Individual SeMet-labeled crystals of truncated
MAP_1272c were briefly transferred to a cryoprotection buffer consisting of well buffer with 30% (v/v)
ethylene glycol and flash cooled in liquid nitrogen.
Three-hundred and sixty 18 oscillation images were
recorded at a high-energy remote wavelength for the
Selenium K-edge (0.9724 Å; 12750 eV). Individual
reflections were indexed, integrated, and merged
such that Friedel mates were kept separate using the
HKL2000 software package.41 Selenium sites were
identified and refined using the AutoSol package
prior to automated model building in AutoBuild, as
implemented in PHENIX.42 The final model, including SeMet substitutions, was the product of iterative
cycles of manual building in COOT43 and refinement
using PHENIX. Data collection and refinement statistics are reported in Table I. With respect to the
MAP_1272c polypeptide chain, the final model consists of residues Gly32–Leu166, contiguous. Additional
information can be found by consulting the Protein
Data Bank (PDB) accession code 3GT2.
Prior to flash cooling in liquid nitrogen,
MAP_1204 crystals were briefly transferred to a cryoprotection solution identical to the precipitant but
supplemented with 2-propanol to a final concentration of 18% (v/v). A native MAP_1204 dataset was
collected at 12398 eV (1 Å) at APS beamline 22-BM.
Reflections from 360 18 images were processed,
indexed, and scaled in HKL2000. The relatively high
Rmerge value associated with this diffraction dataset
likely arises from the observational redundancy provided by the high-symmetry cubic space group of
this crystal. Other metrics of data quality, such as
I>/<r, are in good agreement with generally
accepted criteria for defining the resolution limits of
X-ray diffraction data.44,45 The refined coordinates of
the MAP_1272c truncation were used as a search
model to perform molecular replacement in PHENIX.42 The resultant model was iteratively refined
and manually modified as described above, with the
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exception of two cycles of simulated annealing to
remove model phase bias. Although two copies of the
MAP_1204 polypeptide were found in the asymmetric unit of this crystal form, no noncrystallographic
symmetry averaging was used during the process of
building and refinement. Final data collection and
model refinement statistics are reported in Table II.
The final model accounts for the entire Val109–
Tyr244 polypeptide contiguously in both chains.
Additional information can be found by consulting
the Protein Data Bank (PDB) accession code 3I86.

Circular dichroism (CD) spectropolarimetry
CD spectropolarimetry was used to assess the overall secondary structure content in MAP NlpC/P60
proteins. Purified MAP_1272c, MAP_1204, or
MAP_1204 C155S proteins were dissolved in
phosphate-buffered saline (pH 7.4) and were passed
through a 0.45 lm centrifugal filter immediately
prior to analysis. Samples were diluted to a final
concentration such that the OD280nm was equal to
0.5, which corresponds almost exactly to  0.5 mg/
mL for all proteins. CD spectra were measured from
190 to 260 nm in scanning mode using a Jasco J-815
spectropolarimeter. Five replicate spectra were collected in normal sensitivity mode with a 1 nm bandwidth at a speed of 50 nm/min prior to averaging
and mathematical smoothing using software provided by the manufacturer. Samples were not
degassed, nor were spectra collected under a vacuum; thus, the observations at shorter wavelengths
should be considered unreliable.

enzyme activity was quenched in a 5 min ice bath
and serial dilutions were plated on LB broth and
incubated overnight at 378C to determine percent
survival. Each survival assay was run in triplicate.

Peptidoglycan binding assay
Proteins were quantitated by BCA assay and loaded
onto commercial SDS-PAGE gels (BioRad) stained
with GelCode blue (Thermo Scientific) to standardize between samples. The binding assay was performed essentially as described previously.30
Briefly, insoluble trichloroacetic acid treated peptidoglycan (1 mg/mL) from Staphylococcus aureus
(Sigma chemicals) or Bacillus subtilis (Sigma chemicals) was suspended in binding buffer (0.15M NaCl
and 25mM Na-Hepes, pH 7.0) and incubated with
0.2 mg/mL of each recombinant protein or the positive and negative controls, hen egg white lysozyme
(HEWL) and bovine serum albumin (BSA), all of
which were dialyzed in binding buffer. The protein–
peptidoglycan mixture was incubated for 5 min at
228C to allow binding. The samples were centrifuged at 12,000g for 5 min and only the top half of
the supernatant was collected. The remaining
supernatant was then removed and discarded. Both
the supernatant and pellet fractions were mixed
with loading dye (1% SDS; 50mM Tris, pH 6.8; 1%
2-mercaptoethanol; 10% glycerol) and then separated on 12% SDS-PAGE gels followed by staining
with GelCode blue.

Statistical analysis
Peptidoglycan degradation assay
Purified Bacillus subtilis peptidoglycan (Sigma) was
resuspended in 50 mM NaH2PO4 (pH 6.0) to a concentration of 0.25 mg/mL and added to a 96-well
plate. Peptidoglycan was incubated with 32 lM of
each recombinant protein as determined in pilot
studies. Lysozyme, which served as the positive control, was used at a concentration of 4 lM. All reactions had a final volume of 200 lL and were
performed in a 96-well plate at room temperature
with shaking at 200 rpm on a WVR microplate
shaker. Absorbance was measured at 540 nm every
15 min using a Victor X3 plate reader (Perkin
Elmer). Data were assembled and analyzed using
GraphPad Prism 6.0.

Bacillus subtilis viability assay
An LB broth culture of B. subtilis was incubated
overnight at 378C with shaking at 200 rpm. Mid-log
phase B. subtlilis cells (OD600nm 5 0.1) were added
to tubes containing 20 mM of lysozyme or recombinant protein diluted in 0.13 phosphate-buffered
saline (PBS; 15mM NaCl, 1mM Na2HPO4; pH 7.3)
as indicated. The IpaD protein from Shigella flexneri
was used as a negative control.46 After 60 min,
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Measurements of statistical significance regarding differences in B. subtilis survival were obtained by an
unpaired t test using GraphPad Prism 6.0. The mean
values of each treatment (6SD) were calculated and
compared to that of the negative control (IpaD) by an
unpaired t test to assess statistical significance. Notations: ****p  0.0001; ns, not significant.
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